The Center for Liver Disease and Transplantation at NewYork-Presbyterian is a leader in providing unparalleled medical care for patients with advanced liver failure. Our expert physicians and surgeons from Columbia University and Weill Cornell Medicine employ innovative techniques to expand the donor pool for adults and children facing complex liver diseases. Our program specializes in living donor transplantation, split liver transplantation, and robotic transplant surgery, aiming to reduce wait times and achieve optimal patient outcomes. Discover more about our liver team, the latest advancements in research and clinical care, and how to refer a patient below.
Why referring physicians choose us
We perform the highest number of liver transplants annually in New York State*
We are home to the largest robotic living donor liver transplant program in the country**
New York State's first fully robotic living donor liver transplant***
Refer a patient for advanced liver failure treatment
Partner with us if your patient is facing advanced or complex liver failure. Take one of the steps below, and a member of our team will contact you to discuss your case and the next steps. We accept most insurance plans and accommodate all languages. For convenience, you’ll find a list of our doctors below.
Department leadership
Weill Cornell Medicine
Medical Director, Center for Liver Disease and Transplantation
Weill Cornell Medicine
Chief, Division of Gastroenterology and Hepatology
Columbia
Enterprise Medical Director, Adult Liver Transplantation
Director, Clinical Hepatology
Columbia
Surgical Director, Adult Liver Transplantation
Director, Robotic Liver Surgery Program
Weill Cornell Medicine
Chief, Liver Transplantation and Hepatobiliary Surgery
Surgical Director, Living Donor Liver Transplant Program
Columbia
Director, Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Program
Transplant hepatologists
Transplant surgeons
Services & specialties
- Alcohol related liver disease
- Alpha-1-antitrypsin deficiency
- Autoimmune hepatitis
- Biliary atresia
- Cholangiocarcinoma
- Cirrhosis
- Hepatic encephalopathy
- Hepatitis C
- Hepatocellular carcinoma
- Hereditary hemochromatosis
- Liver metastases
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Neuroendocrine tumors
- Polycystic liver disease
- Primary sclerosing cholangitis
- Viral hepatitis
- Wilson’s disease
The latest in hepatic research
Learn more about how our liver team enhances outcomes for advanced liver disease and transplantation through innovative research and exceptional clinical care.